Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clostridial Infection”

663 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 663 results

Not applicableStudy completedNCT02747017
What this trial is testing

Observational Study of C. Diff in Post-Transplant Patients

Who this might be right for
Clostridium Difficile
University of Minnesota 132
Large-scale testing (Phase 3)Study completedNCT05831189
What this trial is testing

A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection

Who this might be right for
Clostridium Difficile Infection Recurrence
Ferring Pharmaceuticals 41
Testing effectiveness (Phase 2)WithdrawnNCT03643887
What this trial is testing

Phase II Trial of Fecal Microbiota Transplant (FMT) for VRE and CRE Patients

Who this might be right for
Clostridium Difficile Infection
University of Wisconsin, Madison
Large-scale testing (Phase 3)Study completedNCT00797511
What this trial is testing

Immunogenicity and Safety of Adacel Polio Vaccine

Who this might be right for
DiphtheriaTetanusPertussis+1 more
Sanofi 132
Not applicableStudy completedNCT02461901
What this trial is testing

Does Fidaxomicin Therapy Reduce Spread of Clostridium Difficile?

Who this might be right for
Clostridium Difficile Infection
Professor Mark Wilcox 203
Not applicableUnknownNCT06258551
What this trial is testing

Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients

Who this might be right for
Antimicrobial Drug ResistanceAntibiotic Resistant InfectionClostridium Difficile+5 more
The Methodist Hospital Research Institute 1,000
Testing effectiveness (Phase 2)Study completedNCT06112834
What this trial is testing

Tolerability and Immunogenicity of a Single 40-ug Dose of rBV A/B for the Production of BabyBIG®

Who this might be right for
Botulism
California Department of Public Health 25
Large-scale testing (Phase 3)Study completedNCT00313911
What this trial is testing

Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi Pasteur, a Sanofi Company 2,133
Testing effectiveness (Phase 2)WithdrawnNCT01077245
What this trial is testing

Safety and Clinical Effectiveness of Oral Probiotic MIYA-BM to Prevent Recurrent Clostridium Difficile Infections

Who this might be right for
Clostridium Difficile Infection
Osel, Inc.
Early research (Phase 1)Study completedNCT03603665
What this trial is testing

Evaluate the Safety and Pharmacokinetics of NTM-1633 vs Placebo Administered Intravenously in Healthy Adults

Who this might be right for
Botulism
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)Study completedNCT00382304
What this trial is testing

The Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea

Who this might be right for
Pseudomembranous ColitisClostridium Difficile DiarrheaAntibiotic-Associated Diarrhea
Genzyme, a Sanofi Company 24
Large-scale testing (Phase 3)Study completedNCT05320068
What this trial is testing

Oral Vancomycin Vs Placebo in the Prevention of Recurrence of Clostridioides Difficile's Infection

Who this might be right for
Clostridioides Difficile Infection
Julia Orígüen 24
Not applicableStudy completedNCT00446355
What this trial is testing

Clinical Outcomes of Patients With Clostridium Difficile Associated Disease Attributable to Diverse tcdC Genotypes

Who this might be right for
Clostridium Infections
University of Pittsburgh 1,000
Post-approval studies (Phase 4)Study completedNCT02254967
What this trial is testing

A Phase IIIB/IV Study to Compare the Efficacy of Vancomycin Therapy to Extended Duration of Fidaxomicin Therapy in the Clinical Cure of Clostridium Difficile Infection (CDI) in an Older Population

Who this might be right for
Clostridium Difficile
Astellas Pharma Europe Ltd. 364
Large-scale testing (Phase 3)Study completedNCT00385255
What this trial is testing

Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults

Who this might be right for
Acellular PertussisDiphtheriaTetanus
GlaxoSmithKline 1,726
Large-scale testing (Phase 3)WithdrawnNCT07221708
What this trial is testing

Primary Prophylaxis of Clostridioides Difficile Infection With Oral Vancomycin

Who this might be right for
Clostridioides DifficileVancomycin Resistance Enterococcus Faecium
University of Maryland, Baltimore
Large-scale testing (Phase 3)Study completedNCT01267058
What this trial is testing

Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy Adults

Who this might be right for
DiphtheriaPertussisTetanus
GlaxoSmithKline 550
Large-scale testing (Phase 3)Ended earlyNCT01226992
What this trial is testing

Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral Vancomycin

Who this might be right for
Recurrent Clostridium Difficile InfectionLaboratory Confirmed Clostridium Difficile Infection
University Health Network, Toronto 81
Early research (Phase 1)Study completedNCT01551004
What this trial is testing

Phase I Trial of a Single Dose of CRS3123

Who this might be right for
Clostridium Difficile Colitis
National Institute of Allergy and Infectious Diseases (NIAID) 40
Testing effectiveness (Phase 2)Study completedNCT03676634
What this trial is testing

Tolerability and Immunogenicity of rBV A/B for the Production of BabyBIG®

Who this might be right for
Botulism
California Department of Public Health 32
Next Page